Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients With Metastatic or Locally Advanced Urothelial Cancer Without Prior Systemic Therapy
Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients With Metastatic or Locally Advanced Urothelial Cancer Without Prior Systemic Therapy
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is more effective for urinary tract cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of cisplatin plus gemcitabine with or without paclitaxel in treating patients who have stage IV urinary tract cancer.
OBJECTIVES:
OUTLINE: This is a randomized, open-label, multicenter study. Patients are stratified according to participating center, WHO performance status (0 vs 1), and presence of metastatic disease (yes vs no). Patients are randomized to one of two treatment arms.
Patients are followed every 3 months for 2 years and then every 6 months for at least 3 years.
Peer Reviewed and Funded or Endorsed by Cancer Research UK
PROJECTED ACCRUAL: A total of 610 patients (305 per treatment arm) will be accrued for this study within 3.04 years.
DISEASE CHARACTERISTICS:
Histologically confirmed stage IV transitional cell carcinoma of the urothelium (pure or mixed) including bladder, urethra, ureter, and renal pelvis
Ineligible for surgery or radiotherapy with curative intent
Measurable or evaluable disease
No known CNS metastases
PATIENT CHARACTERISTICS:
Age:
Performance status:
Life expectancy:
Hematopoietic:
Hepatic:
Renal:
Cardiovascular:
Other:
PRIOR CONCURRENT THERAPY:
Biologic therapy:
Chemotherapy:
Endocrine therapy:
Radiotherapy:
Surgery:
Tucson, Arizona 85724, United States
Orange, California 92868, United States
Aurora, Colorado 80010, United States
Hines, Illinois 60141, United States
Maywood, Illinois 60153-5500, United States
Kansas City, Kansas 66160-7390, United States
Lexington, Kentucky 40536-0084, United States
Shreveport, Louisiana 71130-3932, United States
New York, New York 10032, United States
Rochester, New York 14642, United States
Oklahoma City, Oklahoma 73104, United States
Charleston, South Carolina 29425, United States
Del Rio, Texas 78840, United States
Lubbock, Texas 79415-3364, United States
San Antonio, Texas 78229-3900, United States
Seattle, Washington 98104, United States
Kelowna, British Columbia V1Y 5L3, Canada
Victoria, British Columbia V8R 6V5, Canada
St. John's, Newfoundland and Labrador A1B 3V6, Canada
Kitchner, Ontario N2G 1G3, Canada
North York, Ontario M2K 1E1, Canada
North York, Ontario M4N 3M5, Canada
Charlottetown, Prince Edward Island C1A 8T5, Canada
Ste-Foy, Quebec G1V 4G5, Canada
Nantes-Saint Herblain, 44805, France
NL'S Hertogenbosch, NL-5211, Netherlands
Newcastle upon Tyne, England NE4 6BE, United Kingdom